a public good project by the
Synthesis
Company
of California

© 2026

Peter Reichardt | doi.page

0 works0 citations0 h-index

Peter Reichardt

Helios Hospital Berlin-Buch(DE)

Publications by Year

Research Areas

Gastrointestinal Tumor Research and Treatment, Sarcoma Diagnosis and Treatment, Gastric Cancer Management and Outcomes, Gastrointestinal disorders and treatments, Chronic Myeloid Leukemia Treatments

Most-Cited Works

→ Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial(2004)1,662 cited
→ Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up(2018)1,598 cited
→ Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial(2012)1,392 cited
→ One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor(2012)957 cited
→ Primary Metastatic Osteosarcoma: Presentation and Outcome of Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols(2003)943 cited
→ Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆(2021)909 cited

→ Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up(2018)751 cited

→ Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO(2005)720 cited

→ Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort(2019)709 cited

→ Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954(2010)709 cited